Incidence and Predictive Factors for Amputations Derived From Charcot's Neuroarthropathy in Persons With Diabetes
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS INC
Autores
BANDEIRA, Mariana A.
WOO, Kevin
GAMBA, Monica A.
SANTOS, Vera L. C. de Gouveia
Citação
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, v.22, n.3, p.509-517, 2023
Resumo
Charcot's neuroarthropathy (CN) is the progressive destruction of the bones and joints of the feet, as a consequence of severe peripheral neuropathy, which predisposes patients to amputations. The purpose of this study was to measure the cumulative incidence of amputations resulting from CN and risk factors among amputated people with diabetes mellitus (DM). This was an epidemiological, observational, and retrospective study of 114 patients with DM who had an amputation involving the lower limbs. Data were collected from 2 specialized outpatient clinics between 2015 and 2019, including socio-demographic and clinical variables (cause of amputation: CN, peripheral arterial disease [PAD], infected ulcers, fracture, osteomyelitis, and others; body mass index [BMI]; 1 or 2 DM, time since DM diagnosis, insulin treatment, glycated hemoglobin; creatinine; smoking and drinking; systemic arterial hypertension, diabetic retinopathy, diabetic kidney disease, diabetic peripheral neuropathy, acute myocardial infarction, PAD, and stroke; characteristics of amputation [level and laterality], in addition to the specific variables related to CN [time of amputation in relation to the diagnosis of CN, diagnosis of CN in the acute phase, and treatment implemented in the acute phase]). We compared socio-demographic and clinical characteristics, including types of amputation, between patients with and without CN. Statistical analyses were performed using the 2 sample t-test or Wilcoxon-Mann-Whitney test, for quantitative variables, and the Pearson's chi(2) test or Fisher's exact test for categorical variables. The investigation of the possible association of predictive factors for a CN amputation was carried out through logistic regression. The amputation caused by CN was present in 27 patients with a cumulative incidence of 23.7% in 5 years. There was a statistically significant association between BMI and the occurrence of CN (odds ratio: 1.083; 95% confidence interval: 1.001-1.173; P = .048); higher values of BMI were associated with a higher occurrence of amputations secondary from CN.
Palavras-chave
epidemiology, incidence, Charcot's neuroarthropathy, amputation, diabetes mellitus
Referências
- Al-Rubeaan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124446
- *AM DIAB ASS, 2020, STANDARDS MEDICAL CA
- [Anonymous], 1985, WHO TECH REP SER, P1
- Astrup A., OBES REV, DOI 10.1046/j.1467-789x.2000.00013.x
- Batista F., 2016, ARTROPATIA CHARCOT C
- Belma Malanda, 2019, IDF GLOBAL FACT SHEE
- Bin Younis B, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0023-4
- Bon AVan., 2011, GLOBAL PERSPECTIVE D, P271
- Boulton AJM., 2019, MEDICINE, V47, P100, DOI [10.1016/j.mpmed.2018.11.001, DOI 10.1016/J.MPMED.2018.11.001]
- Brocco E, 2018, J CARDIOVASC SURG, V59, P670, DOI 10.23736/S0021-9509.18.10606-9
- Burson LK., HOME HEALTHC NOW, DOI 10.1097/NHH.0000000000000348
- Bus SA, 2016, DIABETES-METAB RES, V32, P99, DOI 10.1002/dmrr.2702
- Carvalho VF., 2010, REV MED SAO PAULO, V89, P164
- Chaudhary S, 2019, ACTA DIABETOL, V56, P1259, DOI 10.1007/s00592-019-01376-9
- Dahmen R, 2001, DIABETES CARE, V24, P705, DOI 10.2337/diacare.24.4.705
- De Block CEM, 2005, DIABETES CARE, V28, P1649, DOI 10.2337/diacare.28.7.1649
- Del Core MA., 2018, FOOT ANKLE ORTHOP, V3, DOI [10.1177/2473011418788864, DOI 10.1177/2473011418788864]
- Dixon J, 2017, NEW ZEAL MED J, V130, P62
- Donegan R, 2013, DIABET FOOT ANKLE, V4, DOI 10.3402/dfa.v4i0.21361
- Evans R., 2019, WOUND CARE CANADA, V17, P42
- Ferreira RC, 2010, ACTA ORTOP BRAS, V18, P135, DOI 10.1590/S1413-78522010000300004
- Frykberg Robert G, 2008, Clin Podiatr Med Surg, V25, P17, DOI 10.1016/j.cpm.2007.10.001
- FUNNELL M, 2018, NURSE, V34, P22
- Groop PH, 2005, NAT CLIN PRACT ENDOC, V1, P100, DOI 10.1038/ncpendmet0046
- Güven MF, 2013, DIABET FOOT ANKLE, V4, DOI 10.3402/dfa.v4i0.21177
- Hasan R, 2016, J VASC SURG, V63, p22S, DOI 10.1016/j.jvs.2015.10.005
- Hingorani A, 2016, J VASC SURG, V63, p3S, DOI 10.1016/j.jvs.2015.10.003
- International Diabetes Federation, 2017, IDF CLIN PRACT REC D, DOI 10.13140/RG.2.2.15315.07202
- Jain AKC., 2015, INT SURG J, V2, P26, DOI [10.5455/2349-2902.isj20150205, DOI 10.5455/2349-2902.ISJ20150205]
- Klöting N, 2020, OBESITY, V28, P2266, DOI 10.1002/oby.23041
- Lotfy M, 2017, CURR DIABETES REV, V13, P3, DOI 10.2174/1573399812666151016101622
- Markakis K, 2016, DIABETES-METAB RES, V32, P169, DOI 10.1002/dmrr.2740
- McEwen LN, 2013, J DIABETES COMPLICAT, V27, P588, DOI 10.1016/j.jdiacomp.2013.08.003
- Miquel, 2008, DICT EPIDEMIOLOGY
- National Institute for Health and Care Excellence, 2019, NATL I HEAL CAR EXC, V20, P1, DOI [10.4103/2230-8229.108174, DOI 10.4103/2230-8229.108174]
- Nehring P., 2010, EXP CLIN ENDOCR DIAB, V75, P233, DOI [10.1055/s, DOI 10.1055/S]
- Nilsen FA, 2018, J FOOT ANKLE SURG, V57, P301, DOI 10.1053/j.jfas.2017.10.008
- O'Loughlin A, 2017, IRISH J MED SCI, V186, P151, DOI 10.1007/s11845-016-1508-5
- Pacheco RL., 2017, DIAGN TRAT, V22, P121
- Pagnano RG., 2015, DIABETOL METAB SYNDR, V7, pA17, DOI [10.1186/1758-5996-7-s1-a17, DOI 10.1186/1758-5996-7-S1-A17]
- Petrova NL, 2017, CLIN PODIATR MED SUR, V34, P15, DOI 10.1016/j.cpm.2016.07.003
- Petrova NL., 2019, LIMB SALV DIAB FOOT, P139, DOI [10.1007/978-3-319-17918-6, DOI 10.1007/978-3-319-17918-6]
- Petrova NL., 2016, DIABETES CARE, V22, P1, DOI [10.1016/j.jdiacomp.2013.08.003.Prevalence, DOI 10.1016/J.JDIACOMP.2013.08.003.PREVALENCE]
- Pinheiro Ana, 2014, Rev. Port. Ortop. Traum., V22, P24
- Ramanujam CL, 2017, CLIN PODIATR MED SUR, V34, P1, DOI 10.1016/j.cpm.2016.07.001
- Ramanujam CL, 2014, CLIN PODIATR MED SUR, V31, P487, DOI 10.1016/j.cpm.2013.12.001
- Ramanujam CL, 2011, DIABET FOOT ANKLE, V2, DOI 10.3402/dfa.v2i0.6418
- Rodrigues BT, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5941957
- Rogers LC, 2013, MED CLIN N AM, V97, P847, DOI 10.1016/j.mcna.2013.04.003
- Rogers LC, 2011, DIABETES CARE, V34, P2123, DOI 10.2337/dc11-0844
- Sebastian AP, 2019, DIABETES METAB SYND, V13, P1081, DOI 10.1016/j.dsx.2019.01.008
- Snyder RJ, 2014, J AM PODIAT MED ASSN, V104, P555, DOI 10.7547/8750-7315-104.6.555
- Sociedade Brasileira de Diabetes, 2016, DIR SBD 2015 2016
- Sociedade Brasileira de Diabetes, 2017, DIR DIAB, DOI 10.1086/345100
- Sohn MW, 2010, DIABETES CARE, V33, P98, DOI 10.2337/dc09-1497
- Stuck RM, 2008, AM J MED, V121, P1008, DOI 10.1016/j.amjmed.2008.06.038
- Thorud JC, 2016, J FOOT ANKLE SURG, V55, P1007, DOI 10.1053/j.jfas.2016.05.011
- Turns Martin, 2012, Br J Community Nurs, V17, P424
- Ullah A, 2016, SAUDI PHARM J, V24, P547, DOI 10.1016/j.jsps.2015.03.013
- Varma AK, 2013, J FOOT ANKLE SURG, V52, P740, DOI 10.1053/j.jfas.2013.07.001
- Vieira Lima DP., 2016, REV PORT DIAB, V11, P51
- von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]
- Working Group on the Diabetic Foot (IWGDF), 2019, IWGDF GUID PREV MAN
- World Health Organization, BODY MASS INDEX
- World Union of Wound Healing Societies, 2016, POS DOC LOC MAN DIAB
- Yusof NM, 2015, SINGAP MED J, V56, P626, DOI 10.11622/smedj.2015172
- Zhang B, 2006, J MULTIVARIATE ANAL, V97, P211, DOI 10.1016/j.jmva.2005.01.002
- Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151